These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2407335)

  • 41. Interphase cytogenetics as an adjunct in the cytodiagnosis of urinary bladder carcinoma. A comparative study of cytology, flow cytometry and interphase cytogenetics in bladder washes.
    Cajulis RS; Haines GK; Frias-Hidvegi D; McVary K
    Anal Quant Cytol Histol; 1994 Feb; 16(1):1-10. PubMed ID: 8011035
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of urinary level of NMP22 as a diagnostic marker for stage pTa-pT1 bladder cancer: comparison with urinary cytology and BTA test.
    Del Nero A; Esposito N; Currò A; Biasoni D; Montanari E; Mangiarotti B; Trinchieri A; Zanetti G; Serrago MP; Pisani E
    Eur Urol; 1999 Feb; 35(2):93-7. PubMed ID: 9933801
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of recurrent bladder cancer: NMP22 test or urine cytology?
    Hosseini J; Golshan AR; Mazloomfard MM; Mehrsai AR; Zargar MA; Ayati M; Shakeri S; Jasemi M; Kabiri M
    Urol J; 2012; 9(1):367-72. PubMed ID: 22395834
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhanced detection of bladder cancer in urine cytology with Lewis X, M344 and 19A211 antigens.
    Sagerman PM; Saigo PE; Sheinfeld J; Charitonowics E; Cordon-Cardo C
    Acta Cytol; 1994; 38(4):517-23. PubMed ID: 7913791
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Urine cytology in the follow-up of patients with transitional cell carcinoma of the urinary bladder: is that enough as a single method?
    Raica M; Miclea F; Ioiart I; Minciu R; Drăgan P
    Rom J Morphol Embryol; 1998; 44(1-4):173-8. PubMed ID: 15678859
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Could nuclear matrix protein 22 (NMP22) play a role with urine cytology in screening for bladder cancer?--experience at Kuwait University.
    Kapila K; Kehinde EO; Anim JT; Mojiminiyi OA; Vinsu A; George SS; Al-Maghrebi M; Al-Mulla F
    Cytopathology; 2008 Dec; 19(6):369-74. PubMed ID: 18631356
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytokeratin 20: a new marker for early detection of bladder cell carcinoma?
    Buchumensky V; Klein A; Zemer R; Kessler OJ; Zimlichman S; Nissenkorn I
    J Urol; 1998 Dec; 160(6 Pt 1):1971-4. PubMed ID: 9817302
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical utility of urinary soluble Fas in screening for bladder cancer.
    Srivastava AK; Singh PK; Singh D; Dalela D; Rath SK; Bhatt ML
    Asia Pac J Clin Oncol; 2016 Jun; 12(2):e215-21. PubMed ID: 24576318
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses.
    Lotan Y; Roehrborn CG
    Urology; 2003 Jan; 61(1):109-18; discussion 118. PubMed ID: 12559279
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12].
    Friedrich MG; Hellstern A; Hautmann SH; Noldus I; Huland H
    Urologe A; 2003 Apr; 42(4):523-30. PubMed ID: 12715124
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder.
    Feil G; Zumbrägel A; Päulgen-Nelde HJ; Hennenlotter J; Maurer S; Krause S; Bichler KH; Stenzl A
    Anticancer Res; 2003; 23(2A):963-7. PubMed ID: 12820331
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer.
    Kinoshita H; Ogawa O; Kakehi Y; Mishina M; Mitsumori K; Itoh N; Yamada H; Terachi T; Yoshida O
    J Natl Cancer Inst; 1997 May; 89(10):724-30. PubMed ID: 9168188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Voided urinary cytodiagnosis. Cyto-histologic comparison].
    Zerat L; Fontanière B; Claude JM; Potet F; Verges J
    Ann Urol (Paris); 1988; 22(4):249-53. PubMed ID: 3190165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of malignant cells in voided urine from patients with bladder cancer, a novel monoclonal assay.
    Walker KZ; Russell PJ; Kingsley EA; Philips J; Raghavan D
    J Urol; 1989 Dec; 142(6):1578-83. PubMed ID: 2685375
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Urine concentration of nuclear matrix protein 22 for diagnosis of transitional cell carcinoma of bladder.
    Jamshidian H; Kor K; Djalali M
    Urol J; 2008; 5(4):243-7. PubMed ID: 19101898
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder.
    Shariat SF; Zippe C; Lüdecke G; Boman H; Sanchez-Carbayo M; Casella R; Mian C; Friedrich MG; Eissa S; Akaza H; Sawczuk I; Serretta V; Huland H; Hedelin H; Rupesh R; Miyanaga N; Sagalowsky AI; Wians F; Roehrborn CG; Lotan Y; Perrotte P; Benayoun S; Marberger MJ; Karakiewicz PI
    J Urol; 2005 May; 173(5):1518-25. PubMed ID: 15821471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Voided urine versus bladder washing cytology for detection of urothelial carcinoma: which is better?
    Keller AK; Jensen JB
    Scand J Urol; 2017 Aug; 51(4):290-292. PubMed ID: 28398114
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
    Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
    Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of tumor cells in bladder washings by a monoclonal antibody to human bladder tumor-associated antigen.
    Lin CW; Young DA; Kirley SD; Khaw AH; Prout GR
    J Urol; 1988 Sep; 140(3):672-7. PubMed ID: 3045345
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Urine cytology of transitional cell neoplasms.
    Rife CC; Farrow GM; Utz DC
    Urol Clin North Am; 1979 Oct; 6(3):599-612. PubMed ID: 505675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.